Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been ...
Obstructive sleep apnoea may affect 1 in 5 adults in the UK and USA, costing billions in lost productivity, but can be offset by effective treatment.
A consistent and calming wind-down routine that signals to your brain that it’s time to rest can further support this process. "Activities such as reading, stretching, taking a warm bath or listening ...
Axsome Therapeutics has begun the Phase 3 CLARITY trial of solriamfetol in adults with major depressive disorder and excessive daytime sleepiness. The study focuses on a patient group that currently ...
Obstructive sleep apnea is a serious medical condition characterized by airway obstruction during sleep. In addition to increased risk of physical health concerns such as heart attack and stroke, it ...
Sleep apnoea cases rising in India, PGI doctors warn of life-threatening risks including heart disease, stroke and diabetes if left untreated.
Live webcasts of the presentations at the TD Cowen, Leerink, and Citizens conferences can be accessed on the “Webcasts & Presentations” page of the “Investors” section of the Company’s website at ...
Experts have outlined crucial signs that might indicate snoring is a symptom of a more concerning underlying problem ...
MARYSVILLE, OH - February 24, 2026 - PRESSADVANTAGE - Sleep Better Marysville has announced the expansion of its sleep ...
Untreated obstructive sleep apnea may be costing the UK and US economies billions of pounds/dollars in lost productivity ...
People who could harm others due to excessive daytime sleepiness should be screened for obstructive sleep apnoea, claims a ...
One of sleep apnea's earliest symptoms is very frequently missed by sufferers, and instead is put down to other causes - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results